Exchange
OTCQB
Every company in the roster listed on OTCQB.
Research
Compare financial metrics on this exchange
Research adds market cap, cash, runway and annualized R&D metrics with metric-specific sorting.
Views
2 of 2 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 CytoDynCYDY · OTCQB | 1 asset: 1 Ph 3 | LeronlimabPhase 3 · HIVPartial signal | Jan 2028Leronlimab · Phase 2 |
 Emmaus Life SciencesEMMA · OTCQB | 1 asset: 1 approved | Approved assets only | None on record |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).